CSIMarket Company Name, Ticker, Suppliers, else..


Cytek Biosciences Inc   (NASDAQ: CTKB)
Other Ticker:  
 

Cytek Biosciences Inc

CTKB's Fundamental analysis



Looking into Cytek Biosciences Inc growth rates, revenue grew by 8.11 % in III. Quarter 2024 from the same quarter a year ago.

Laboratory Analytical Instruments industry recorded growth of revenues by 1.81 %

Cytek Biosciences Inc realized net income compared to net loss a year ago in III. Quarter 2024

• More on CTKB's Growth


Cytek Biosciences Inc
realized a net loss in trailing twelve months.

Cytek Biosciences Inc realized cash reduction of $ -0.01 per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
12.93
PE TTM    
Company's Price to Sales ratio is at 4.35.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.69.


• More on CTKB's Valuation
 
 Total Debt (Millions $) 1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 789,181
 Net Income/Employee (TTM) $ -39,996
 Receivable Turnover (TTM) 3.94
 Tangible Book Value (Per Share $) 2.63

Cytek Biosciences Inc
realized net loss in trailing twelve months.

Cytek Biosciences Inc realized cash outflow of $ -0.01per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
12.93
PE TTM    
Company's Price to Sales ratio is at 4.35.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.69.

Cytek Biosciences Inc Price to Book Ratio is at 2.26 lower than Industry Avg. of 293.7. and higher than S&P 500 Avg. of 0.01

• More on CTKB's Valuation

•  Market Capitalization (Millions $) 871
•  Shares Outstanding (Millions) 133
•  Employees 254
•  Revenues (TTM) (Millions $) 200
•  Net Income (TTM) (Millions $) -10
•  Cash Flow (TTM) (Millions $) -1
•  Capital Exp. (TTM) (Millions $) -4
•  Total Debt (Millions $) 1
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 789,181
•  Net Income/Employee(TTM) $ -39,996
•  Receivable Turnover Ratio (TTM) 3.94
•  Tangible Book Value (Per Share $) 2.63

•  Market Capitalization (Millions $) 871
•  Shares Outstanding (Millions) 133
•  Employees 254
•  Revenues (TTM) (Millions $) 200
•  Net Income (TTM) (Millions $) -10
•  Cash Flow (TTM) (Millions $) -1
•  Capital Exp. (TTM) (Millions $) -4





  Ratio
•   Capital Ratio (MRQ) 6.21
•  Total Debt to Equity (MRQ) 0
•  Tangible Leverage Ratio (MRQ) 0.28
•  Asset Turnover Ratio (TTM) 0.42
•  Inventory Turnover Ratio (TTM) 1.69





Cytek Biosciences Inc net profit margin of 1.84 % is currently ranking no. 8 in Laboratory Analytical Instruments industry, ranking no. 172 in Healthcare sector and number 2015 in S&P 500.

• More on CTKB's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com